Literature DB >> 11495166

Psychopathy and community violence among civil psychiatric patients: results from the MacArthur Violence Risk Assessment Study.

J L Skeem1, E P Mulvey.   

Abstract

Although psychopathy is recognized as a relatively strong risk factor for violence among inmates and mentally disordered offenders, few studies have examined the extent to which its predictive power generalizes to civil psychiatric samples. Using data on 1,136 patients from the MacArthur Violence Risk Assessment project, this study examined whether the 2 scales that underlie the Psychopathy Checklist: Screening Version (PCL:SV) measure a unique personality construct that predicts violence among civil patients. The results indicate that the PCL:SV is a relatively strong predictor of violence. The PCL:SV's predictive power is substantially reduced, but remains significant, after controlling for a host of covariates that reflect antisocial behavior and personality disorders other than psychopathy. However, the predictive power of the PCL:SV is not based on its assessment of the core traits of psychopathy, as traditionally construed. Implications for the 2-factor model that underlies the PCL measures and for risk assessment practice are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11495166

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  20 in total

1.  Multimethod assessment of psychopathy in relation to factors of internalizing and externalizing from the Personality Assessment Inventory: the impact of method variance and suppressor effects.

Authors:  Daniel M Blonigen; Christopher J Patrick; Kevin S Douglas; Norman G Poythress; Jennifer L Skeem; Scott O Lilienfeld; John F Edens; Robert F Krueger
Journal:  Psychol Assess       Date:  2010-03

2.  Investigating different factor structures of the psychopathy checklist: youth version: confirmatory factor analytic findings.

Authors:  Shayne Jones; Elizabeth Cauffman; Joshua D Miller; Edward Mulvey
Journal:  Psychol Assess       Date:  2006-03

3.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

4.  Psychopathy and negative emotionality: analyses of suppressor effects reveal distinct relations with emotional distress, fearfulness, and anger-hostility.

Authors:  Brian M Hicks; Christopher J Patrick
Journal:  J Abnorm Psychol       Date:  2006-05

5.  Gender differences in emotional risk for self- and other-directed violence among externalizing adults.

Authors:  Naomi Sadeh; Shabnam Javdani; M Sima Finy; Edelyn Verona
Journal:  J Consult Clin Psychol       Date:  2011-02

6.  Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

7.  Parallel syndromes: two dimensions of narcissism and the facets of psychopathic personality in criminally involved individuals.

Authors:  Michelle Schoenleber; Naomi Sadeh; Edelyn Verona
Journal:  Personal Disord       Date:  2011-04

8.  Borderline Personality Disorder Among Jail Inmates: How Common and How Distinct?

Authors:  Courtney Conn; Rebecca Warden; Jeffrey Stuewig; Elysha H Kim; Laura Harty; Mark Hastings; June P Tangney
Journal:  Correct Compend       Date:  2010

9.  The relationship of outwardly-directed aggression to suicidal ideation and suicide attempts across two high-risk samples.

Authors:  Marc T Swogger; Kimberly A Van Orden; Kenneth R Conner
Journal:  Psychol Violence       Date:  2014-04-01

10.  Psychopathic predators? Getting specific about the relation between psychopathy and violence.

Authors:  Jacqueline P Camp; Jennifer L Skeem; Kimberly Barchard; Scott O Lilienfeld; Norman G Poythress
Journal:  J Consult Clin Psychol       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.